Keywords: proposed, drug, patent, extensions, cost, consumers, billion
Proposed drug patent extensions "will cost US consumers $11 billion"
Article | 09 August 1999
The US Senate's proposed Drug Patent Term Restoration Review ProcedureAct of 1999 (S 1172) would cost consumers over $11 billion during 2002-2012, according ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
